Immustrip(Tm) SM Elisa Test System
FDA 510(k) K873741 · Immunomedics, Inc.
510(k) numberK873741
Submission
- Device name
- Immustrip(Tm) SM Elisa Test System
- Applicant
- Immunomedics, Inc.
Newark, NJ, US - Received
- September 16, 1987
- Decision date
- November 4, 1987
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
Device classification
- Product code
- LKP – Anti-Sm Antibody, Antigen And Control
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 866.5100
- Specialty
- Immunology
Other 510(k)s with product code LKP
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K202067 | EliA SmDP-SLKP · Traditional | Phadia AB | 07/14/2021SE |
| K183007 | EliA SmDP ImmunoassayLKP · Traditional | Phadia AB | 12/24/2018SE |
| K132631 | Eia SMDP ImmunoassayLKP · Traditional | Phadia US, Inc. | 08/29/2014SE |
| K123593 | Quanta Flash SM, Quanta Flash RNP, Quanta Flash SM Calibrators, Quanta Flash RNP…LKP · Traditional | Inova Diagnostics, Inc. | 04/17/2013SE |
| K051066 | Theratest El-Ana ProfilesLKP · Traditional | Theratest Laboratories, Inc. | 10/07/2005SE |
| K042629 | Varelisa SM Antibodies, Model 18296LKP · Traditional | Sweden Diagnostics (Germany) GmbH | 12/08/2004SE |
| K024219 | Liquichek Anti-Sm Control, Positive, Catalog #115LKP · Traditional | Bio-Rad | 01/15/2003SE |
| K013263 | Fred Hutchinson Cancer Research Center Enzyme Anti-Sr Protein Antibody TestLKP · Traditional | Fred Hutchinson Cancer Research Center | 07/29/2002SE |
| K000755 | Rhigene MESACUP2 Test- SMLKP · Traditional | Rhigene, Inc. | 05/09/2000SE |
| K000312 | Varelisa SM AntibodiesLKP · Traditional | Pharmacia & Upjohn Co. | 03/17/2000SE |
More from Pharmacia & Upjohn Co.
Questions and answers
When was Immustrip(Tm) SM Elisa Test System cleared by the FDA?
Immustrip(Tm) SM Elisa Test System (K873741) received a 510(k) decision of Substantially Equivalent on November 4, 1987, 49 days after the submission was received.
What is the product code of K873741?
The FDA product code is LKP – Anti-Sm Antibody, Antigen And Control, a Class II (moderate risk) device regulated under 21 CFR 866.5100.